These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 23133312)

  • 41. Regulation of the T Cell Response by CD39.
    Takenaka MC; Robson S; Quintana FJ
    Trends Immunol; 2016 Jul; 37(7):427-439. PubMed ID: 27236363
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of CD73 in Disease: Promising Prognostic Indicator and Therapeutic Target.
    Yang J; Liao X; Yu J; Zhou P
    Curr Med Chem; 2018; 25(19):2260-2271. PubMed ID: 29345574
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extracellular purine metabolism and signaling of CD73-derived adenosine in murine Treg and Teff cells.
    Romio M; Reinbeck B; Bongardt S; Hüls S; Burghoff S; Schrader J
    Am J Physiol Cell Physiol; 2011 Aug; 301(2):C530-9. PubMed ID: 21593451
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting cancer-derived adenosine: new therapeutic approaches.
    Young A; Mittal D; Stagg J; Smyth MJ
    Cancer Discov; 2014 Aug; 4(8):879-88. PubMed ID: 25035124
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeting A2 adenosine receptors in cancer.
    Allard D; Turcotte M; Stagg J
    Immunol Cell Biol; 2017 Apr; 95(4):333-339. PubMed ID: 28174424
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ecto-5'-nucleotidase (CD73)-mediated extracellular adenosine production plays a critical role in hepatic fibrosis.
    Peng Z; Fernandez P; Wilder T; Yee H; Chiriboga L; Chan ES; Cronstein BN
    Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):821-4. PubMed ID: 18600546
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD73 on T Cells Orchestrates Cardiac Wound Healing After Myocardial Infarction by Purinergic Metabolic Reprogramming.
    Borg N; Alter C; Görldt N; Jacoby C; Ding Z; Steckel B; Quast C; Bönner F; Friebe D; Temme S; Flögel U; Schrader J
    Circulation; 2017 Jul; 136(3):297-313. PubMed ID: 28432149
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ectonucleotidases in Intestinal and Hepatic Inflammation.
    Vuerich M; Robson SC; Longhi MS
    Front Immunol; 2019; 10():507. PubMed ID: 30941139
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ecto-5'-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells.
    Wang L; Zhou X; Zhou T; Ma D; Chen S; Zhi X; Yin L; Shao Z; Ou Z; Zhou P
    J Cancer Res Clin Oncol; 2008 Mar; 134(3):365-72. PubMed ID: 17671792
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Generation and Function of Non-cell-bound CD73 in Inflammation.
    Schneider E; Rissiek A; Winzer R; Puig B; Rissiek B; Haag F; Mittrücker HW; Magnus T; Tolosa E
    Front Immunol; 2019; 10():1729. PubMed ID: 31404305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice.
    Bao R; Shui X; Hou J; Li J; Deng X; Zhu X; Yang T
    Int J Mol Med; 2016 Sep; 38(3):969-75. PubMed ID: 27430240
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adenosinergic Immunosuppression by Human Mesenchymal Stromal Cells Requires Co-Operation with T cells.
    Kerkelä E; Laitinen A; Räbinä J; Valkonen S; Takatalo M; Larjo A; Veijola J; Lampinen M; Siljander P; Lehenkari P; Alfthan K; Laitinen S
    Stem Cells; 2016 Mar; 34(3):781-90. PubMed ID: 26731338
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer.
    Kazemi MH; Raoofi Mohseni S; Hojjat-Farsangi M; Anvari E; Ghalamfarsa G; Mohammadi H; Jadidi-Niaragh F
    J Cell Physiol; 2018 Mar; 233(3):2032-2057. PubMed ID: 28233320
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discovery of natural product ellagic acid as a potent CD73 and CD39 dual inhibitor.
    Wang Y; Wang C; Zhu Y; Zhang Y; Chen B; Wu Y; Yao J; Miao Z
    Bioorg Med Chem Lett; 2021 Feb; 34():127758. PubMed ID: 33359608
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metabolic crosstalk: Extracellular ATP and the tumor microenvironment in cancer progression and therapy.
    Shukla S; Dalai P; Agrawal-Rajput R
    Cell Signal; 2024 Sep; 121():111281. PubMed ID: 38945420
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Immune regulation via the generation of extracellular adenosine by CD73].
    Tsukamoto H
    Seikagaku; 2014 Dec; 86(6):766-9. PubMed ID: 25675814
    [No Abstract]   [Full Text] [Related]  

  • 57. Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity.
    Kashyap AS; Thelemann T; Klar R; Kallert SM; Festag J; Buchi M; Hinterwimmer L; Schell M; Michel S; Jaschinski F; Zippelius A
    J Immunother Cancer; 2019 Mar; 7(1):67. PubMed ID: 30871609
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endogenous production of extracellular adenosine by trabecular meshwork cells: potential role in outflow regulation.
    Wu J; Li G; Luna C; Spasojevic I; Epstein DL; Gonzalez P
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):7142-8. PubMed ID: 22997289
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production.
    Clayton A; Al-Taei S; Webber J; Mason MD; Tabi Z
    J Immunol; 2011 Jul; 187(2):676-83. PubMed ID: 21677139
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD39 and CD73 in the aortic valve-biochemical and immunohistochemical analysis in valve cell populations and its changes in valve mineralization.
    Kaniewska-Bednarczuk E; Kutryb-Zajac B; Sarathchandra P; Pelikant-Malecka I; Sielicka A; Piotrowska I; Slominska EM; Chester AH; Yacoub MH; Smolenski RT
    Cardiovasc Pathol; 2018; 36():53-63. PubMed ID: 30056298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.